Dolby Laboratories (DLB)
Return on equity (ROE)
| Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 261,825 | 200,656 | 184,087 | 310,227 | 231,363 |
| Total stockholders’ equity | US$ in thousands | 2,477,160 | 2,355,100 | 2,246,180 | 2,597,980 | 2,432,640 |
| ROE | 10.57% | 8.52% | 8.20% | 11.94% | 9.51% |
September 30, 2024 calculation
ROE = Net income ÷ Total stockholders’ equity
= $261,825K ÷ $2,477,160K
= 10.57%
Dolby Laboratories' return on equity (ROE) has fluctuated over the past five years. In the most recent fiscal year (ending September 30, 2024), the ROE was 10.57%, showing an improvement compared to the prior year. The ROE was higher than in the two preceding years (8.52% in 2023 and 8.20% in 2022), but lower than the level in 2021 (11.94%). Overall, Dolby Laboratories has maintained a relatively stable ROE performance, indicating the company's ability to generate profit from its shareholders' equity. Further analysis of the company's profitability and asset utilization ratios could provide additional insights into its financial performance and efficiency.
Peer comparison
Sep 30, 2024